articles

EMED – down but far from out – Long Chat with CEO: Buy

Tom Winnifrith Thursday 4 October 2012

 

Share this

AIM listed EMED (LSE:EMED) has been on the point of starting to build a huge copper mine in Spain for ages. But getting the consents needed seems harder than finding a 17 year old virgin in Romford. And EMED is still not there. Hence, having tipped the shares at 14.75p back in July 2007 and with the stock at 9.625p today I look like a bit of a schmucko. Apologies for that. However, I had a long chat with CEO Harry Adams this week and I sense that we are almost there and that now would be a good time to buy. Here is why.

Read the full article on TradingResearchPoint.com | Comments
About Tom Winnifrith
Bio
Tom Winnifrith is the editor of TomWinnifrith.com. When he is not harvesting olives in Greece, he is (planning to) raise goats in Wales.
Twitter
@TomWinnifrith
Email
[email protected]
Read next

Tom Winnifrith Bearcast: Both ADVFN & Versarien forced to fess up thanks directly to my actions

Both Versarien (VRS) and ADVFN (AFN) have been forced to issue major ‘fess ups today directly as a result of my actions. I explain how both cases show just why AIM is not working at all, naming names why the Nomad system is failing you all and what happens next. And yes it is a day of fecking triumph for me and this website.

On ShareProphets
Tuesday 21 January 2020
TomWinnifrith.com Copyright © . All rights reserved.
Created by Everywhen